Intuitive Surgical, Inc. $ISRG Shares Acquired by Douglas Lane & Associates LLC

Douglas Lane & Associates LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 112.6% in the third quarter, HoldingsChannel.com reports. The firm owned 102,898 shares of the medical equipment provider’s stock after purchasing an additional 54,499 shares during the quarter. Douglas Lane & Associates LLC’s holdings in Intuitive Surgical were worth $41,842,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Bank of New York Mellon Corp acquired a new stake in shares of Intuitive Surgical in the second quarter valued at approximately $1,335,753,000. J. Stern & Co. LLP increased its stake in Intuitive Surgical by 18,504.6% during the 4th quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock worth $1,204,788,000 after acquiring an additional 2,115,814 shares during the period. Arrowstreet Capital Limited Partnership raised its holdings in Intuitive Surgical by 95.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after acquiring an additional 1,027,475 shares in the last quarter. Polen Capital Management LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $477,225,000. Finally, Invesco Ltd. lifted its position in shares of Intuitive Surgical by 17.4% during the 4th quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock valued at $2,338,350,000 after acquiring an additional 611,268 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. Barclays upgraded Intuitive Surgical to a “strong-buy” rating in a research report on Wednesday. BMO Capital Markets reiterated an “outperform” rating on shares of Intuitive Surgical in a research note on Monday, July 20th. BTIG Research reissued a “buy” rating and issued a $469.00 target price on shares of Intuitive Surgical in a report on Tuesday, September 8th. Bank of America dropped their target price on shares of Intuitive Surgical from $520.00 to $515.00 in a research report on Friday, June 12th. Finally, Mizuho set a $500.00 price target on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research report on Wednesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $502.53.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock traded up $9.42 during midday trading on Friday, hitting $424.83. 691,103 shares of the company traded hands, compared to its average volume of 2,414,546. The firm’s fifty day moving average price is $384.95 and its 200-day moving average price is $411.17. The stock has a market cap of $150.08 billion, a price-to-earnings ratio of 48.71, a PEG ratio of 3.13 and a beta of 1.46. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same quarter in the prior year, the firm earned $1.81 EPS. The firm’s revenue was up 18.4% compared to the same quarter last year. Equities research analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analyst upgrades support the stock: Barclays initiated coverage at Overweight and was also reported to have upgraded ISRG to “strong buy,” citing the company’s high-quality business and durable position in medical devices. Barclays bullish initiation
• Positive Sentiment: Piper Sandler issued a Buy rating, adding to the constructive analyst sentiment surrounding Intuitive Surgical. Piper Sandler Buy rating
• Positive Sentiment: The da Vinci SP single-port platform is gaining momentum: Rising procedures, utilization and system placements, along with broader indications and international adoption, could create another sizable growth franchise for ISRG. Single-port platform growth
• Positive Sentiment: Recent optimism also reflects expectations for continued year-over-year revenue and earnings growth. Intuitive Surgical’s latest reported quarter showed revenue growth of 18.4% and earnings that exceeded analyst estimates, reinforcing its fundamental momentum.
• Neutral Sentiment: Wall Street’s bullish consensus comes with a caveat: Average brokerage recommendations suggest buying ISRG, but such ratings can be overly optimistic because they are produced by sell-side analysts. Wall Street analyst consensus
• Neutral Sentiment: Premarket trading indicated little movement, suggesting investors may be waiting for additional information from the upcoming earnings release before making larger moves.
• Negative Sentiment: Competition and valuation remain risks. Commentary highlighted growing rivalry, particularly from Johnson & Johnson, while ISRG’s premium valuation could limit upside if growth or procedure volumes disappoint. Jim Cramer questioned the company’s competitive outlook for these reasons. Competition concerns

Insider Activity at Intuitive Surgical

In related news, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the sale, the executive vice president owned 5,320 shares in the company, valued at $2,016,280. The trade was a 6.99% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of the company’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $375.57, for a total value of $28,918.89. Following the completion of the transaction, the executive vice president directly owned 881 shares of the company’s stock, valued at approximately $330,877.17. The trade was a 8.04% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 12,370 shares of company stock valued at $4,891,989. 0.60% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.